West Hill Capital led the oversubscribed follow-on investment to fund team growth and product expansion.
"One of our key goals is to eliminate all forms of rental deposits including £4.5bn of cash tied up in rental deposits and deposit alternative products by December 2021."
The oversubscribed round was led by Cambridge Enterprise and will fund the company's transition into drug development.
"We are pleased to welcome on board our new investors and appreciate their confidence in our business. Our aim is to replicate the specificity of biologics in the powerful and scalable form of a small molecule, to treat devastating diseases where there are currently no treatment options. We have proven the strength of our platform in tapping unexplored parts of the chemical universe to find novel and specific hits for currently undruggable targets, and are excited to now be able to invest in our own pipeline of drug discovery programmes, as well as to develop further strategic partnerships."
The seed round was led by Global Founders Capital and Partech with backing from existing investors.
"We are excited to find partners who will accompany us on this journey to build new, employer-based trust layers for financial markets and have raised €5.6m from them"
HearstLab launches its UK presence by backing the London financial technology company.
"We are excited to announce that Akoni will be our first investment in the U.K. Their digital tools and customer-centric experience are unmatched, and we look forward to helping them continue to grow and innovate,"